Translating Science into Survival: Report on the Third International Cancer Immunotherapy Conference

Cancer Immunol Res. 2018 Jan;6(1):10-13. doi: 10.1158/2326-6066.CIR-17-0656.

Abstract

On September 6 to 9, 2017, in Mainz, Germany, the Third International Cancer Immunotherapy Conference was hosted jointly by the Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research. For the third straight year, more than 1,400 people attended the four-day event, which covered the latest advances in cancer immunology and immunotherapy. This report provides an overview of the main topics discussed. Cancer Immunol Res; 6(1); 10-13. ©2017 AACR.

Publication types

  • Congress

MeSH terms

  • Animals
  • Antigens, Neoplasm / immunology
  • Biomarkers
  • Combined Modality Therapy
  • Genetic Therapy
  • Humans
  • Immunotherapy* / adverse effects
  • Immunotherapy* / methods
  • Molecular Targeted Therapy
  • Neoplasms / immunology*
  • Neoplasms / mortality
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Prognosis
  • Translational Research, Biomedical*
  • Treatment Outcome

Substances

  • Antigens, Neoplasm
  • Biomarkers